Device price ‘transparency’ bill a long shot in 110th Congress Feb. 28, 2008 By Mark McCarty No Comments
Riegel not likely the best case for testing pre-emption issue Feb. 25, 2008 By Mark McCarty No Comments
Washington roundup: Warning letters indicate some firms casual about quality control Feb. 22, 2008 By Mark McCarty No Comments
Device price ‘transparency’ bill a very long shot in 110th Congress Feb. 21, 2008 By Mark McCarty No Comments
Committee seeks out HIT plan that’s not ‘a festival of waste’ Feb. 15, 2008 By Mark McCarty No Comments
Heparin mystery so far resistant to the best efforts of CDC, FDA Feb. 13, 2008 By Mark McCarty No Comments
